Mizuho lifts target for Humana stock to USD 495.00

Published on 10/15/2026 at 22:21 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Humana will report third-quarter results on November 6, 2026. Humana stock costs EUR 385.00 on October 15, 2026 at 10:19 p.m. CEST in after-hours trading.

Target and reporting date

Mizuho raised its Humana target from USD 468.00 to USD 495.00 on October 13, 2026.
Humana plans to release third-quarter 2026 results on November 6, 2026.
Humana stock costs EUR 385.00 at Lang & Schwarz on October 15, 2026 at 10:19 p.m. CEST.
Humana had a market capitalization of USD 51.9 billion and a P/E ratio of 40.93.

Aquarellmalerei der Skyline von Charlotte mit Industriegebäuden und weichen Pastellfarben — Honeywell US4448591028 Aquarell-Illustration des Charlotte Stadtpanoramas mit nahen Industrieanlagen und sanften Pastellfarben, Illustration mit AI erstellt.

Mizuho raised its Humana price target from USD 468.00 to USD 495.00 on October 13, 2026, while maintaining an Outperform rating, according to MarketBeat. That target is 14.53 percent above the USD 432.20 Humana quote on the New York Stock Exchange at 4:02 p.m. ET on October 15, 2026. Humana stock stood at EUR 385.00 at Lang & Schwarz on October 15, 2026 at 10:19 p.m. CEST in after-hours trading.

Results date sets the next checkpoint

Humana's investor-relations page schedules the release of third-quarter 2026 results for November 6, 2026, followed by an earnings conference call at 8:00 a.m. ET, according to Humana. The company also lists an investor update for December 10, 2026. Those dates give the stock two defined checkpoints for medical-cost trends, Medicare Advantage performance and full-year guidance.

Quarterly figures remain substantial

For the second quarter of 2026, Humana reported revenue of USD 40.89 billion against analyst estimates of USD 40.58 billion, while earnings per share reached USD 7.61 versus USD 7.27 expected, MarketBeat reported. Revenue rose 26.20 percent from the year-earlier quarter. The report also put Humana's net margin at 0.88 percent and return on equity at 11.20 percent.

Humana's latest market profile shows a USD 51.9 billion market capitalization and a P/E ratio of 40.93. The company paid a quarterly dividend, with the trailing dividend yield listed at 0.01 percent in the October 15, 2026 quote. The valuation leaves the November results as the next test of whether earnings can support the recent share-price recovery.

Comparison with peers

Humana (NYSE, USD): P/E 40.93, market capitalization USD 51.9 billion.
Cigna (NYSE, USD): minus 0.11 percent, P/E 12.37, market capitalization USD 79.0 billion.
Elevance Health (NYSE, USD): plus 0.08 percent, P/E 19.04, market capitalization USD 92.9 billion.

Price position and trading frame

Humana's USD 432.20 home-exchange quote stood 5.32 percent below its 52-week high of USD 456.50 on October 15, 2026. The 52-week low was USD 163.11. The same quote showed 979,501 shares traded against an average volume of 1,326,931 shares.

Stock price in euros

The euro quotation places Humana well above its September levels, when German-market listings were below EUR 400. The current price is an after-hours indication for investors tracking the stock from Germany.

Humana stock was trading at EUR 385.00 at Lang & Schwarz on October 15, 2026 at 10:19 p.m. CEST.

The further course of trading is shown by the continuously updated real-time quote of Humana stock.